Targeted cancer drugs may replace chemo for some patients — and drugmakers say they're getting closer

cnbc.com/2025/06/17/adc-cancer-drugs-pfizer-astrazeneca-merck-bet-on-chemo-replacement.html

Companies like AstraZeneca, Daiichi Sankyo, Pfizer and Merck are learning from previous setbacks in the ADC space to improve their efficacy and safety.

This story appeared on cnbc.com, 2025-06-17 11:00:01.
The Entire Business World on a Single Page. Free to Use →